SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently surging, fueled by recent analyst upgrades, substantial government support for its US-based foundries, and intense speculation around potential major partnerships. Community sentiment is sharply divided, with jubilant bulls celebrating significant gains and anticipating a massive turnaround, while others warn of an unsustainable rally ahead of its anticipated earnings report.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to recent actions by NOAA to streamline deep-sea mining permits, signaling a faster path to commercial recovery for U.S. companies. This regulatory shift, coupled with an upcoming Congressional hearing featuring TMC's CEO, is driving significant bullish sentiment among investors who view critical deep-sea minerals as a national security priority. The community is actively discussing the potential for a short squeeze amidst high short interest and the long-term value proposition for the sector.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is trending amid an extreme arctic cold front and polar vortex sweeping across the U.S., significantly driving up natural gas demand and futures prices. The community is actively discussing intense price volatility, the potential for a short squeeze, and the impact on natural gas storage levels, while also highlighting the inherent "widow maker" risks of leveraged natural gas ETFs.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending after a Neutron rocket Stage 1 tank rupture during qualification testing, sparking a polarized debate among investors. While bulls interpret this as a normal and necessary part of stress testing, highlighting the company's robust Electron launch record and significant defense contracts, bears are concerned about potential delays to the Neutron program and a possible stock correction.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is actively trending due to compelling Phase 1 clinical trial data for its eczema treatment, soquelitinib, which sparked a significant price surge. This momentum is now challenged by a proposed $150 million public offering, causing a sharp divide among investors. Community discussions are intensely focused on the potential for massive dilution versus the drug's long-term promise and the possibility of a short squeeze.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

MiMedx Group is trending amid significant community concern over upcoming CMS reimbursement changes set to impact high-average selling price wound care products in 2026. Discussions highlight widespread bearish sentiment, with many anticipating substantial revenue declines and raising allegations of past billing improprieties involving products like Celera and Emerge. This regulatory uncertainty compounds frustration over the company's declining stock performance and perceived lack of communication from management regarding strategic responses or buybacks.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing extreme volatility as natural gas prices surge due to forecasts of an intense Arctic freeze across the U.S. The community is actively discussing entry and exit points, keenly aware of the "widow maker" reputation of these leveraged ETFs amid dramatic price swings. Many are attempting to capitalize on the rapid moves, while others caution against the inherent risks of such instruments.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed (PAVM) is trending due to excitement over its subsidiary, Lucid Diagnostics, securing a significant U.S. Department of Veterans Affairs contract for its EsoGuard esophageal cancer screening test. The community is actively discussing the stock's low float and recent reverse split, fueling speculation about a potential short squeeze and further price appreciation. While many anticipate continued momentum, others remain cautious about its high volatility and the potential for future share dilution.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is experiencing a notable rally after President Trump announced a halt to planned tariffs on Europe, citing a "framework" deal with NATO regarding Greenland. This move is sparking widespread community discussion about a predictable "TACO trade" pattern where prior threats are reversed, creating significant market volatility and opportunities for dip-buying despite frustrations over perceived manipulation. The reduced geopolitical and trade uncertainty is broadly benefiting the tech-heavy index.

Saakuru is a consumer-centric L2 protocol with zero transaction fees based on OP Stack to create a frictionless experience for any application. Using the Saakuru Protocol alongside the Saakuru Developer Suite enables any product to add Web3 capability in just one day. The powerful and developer-friendly product suite allows a cost-efficient and seamless transition from Web2 to Web3.  The Saakuru Protocol is already live &amp; records more than 1.4 million transactions/week*, which already puts it into the top 20 public blockchains by transactions per week only nine months after network launch. This quick transaction growth is mainly influenced by its gasless nature and very fast block time. On top of that, Saakuru Labs has launched its own Developer Suite: a comprehensive set of highly interoperable modules like Mobile Wallet SDK, NFT management platform, Blockchain data API, and Gamification API, which allows products to embed essential Web3 modules directly to their products significantly reducing cost and speed for any go-to-market strategy.  The Saakuru token is a multi-purpose (utility &amp; governance) token of the Saakuru Protocol, notable for its innovative burning mechanism that methodically reduces supply through transaction fees, developer profits, and governance actions. Its demand is driven by a unique credit system that sustains a gas-less blockchain environment, enabling developers to stake SKR tokens to decrease operational costs. This model promotes active ecosystem participation, ensuring the token's utility and fostering sustainable growth.

Saakuru

Saakuru ($SKR) is trending strongly due to its recent listing on a major exchange and its association as a Solana network token. The community is buzzing about significant price movements, drawing comparisons to successful tokens like BONK, and widely discussing reports of airdrops. This rapid ascent is fueling intense speculation and discussions around potential entry points among crypto enthusiasts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Antares Pharma is a revenue-generating product-focused specialty pharmaceutical company that has developed three proprietary platforms, two of which now include FDA-approved products. Its products typically improve safety and efficacy profiles by minimizing dosing and reducing side effects while improving patient compliance. It focuses on self-injection pharmaceutical products and technologies and topical gel-based products. Its subcutaneous injection technology platforms include Vibex disposable pressure-assisted auto-injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors.

Antares Pharma Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

ATRS
Antares Pharma Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ATRS News

ATRSAntares Pharma Inc